Effect of a non-steroidal anti-inflammatory drug on tissue levels of immunoreactive prostaglandin E2, immunoreactive leukotriene, and pain after periodontal surgery

Journal of Periodontology

Volumn 67, Issue 12, 1996, Pages 1307-1316

  O'Brien, Tiernan P ^a,b   Roszkowski, Mark T ^a   Wolff, Larry F ^c,d   Hinrichs, James E ^c   Hargreaves, Kenneth M ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Department of Preventive Sciences ^*

^c Division of Periodontology   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

ibuprofen therapeutic use; leukotriene B4; pain, measurement; pain, postoperative prevention and care

Indexed keywords

LEUKOTRIENE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROSTAGLANDIN E2;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; ORAL DRUG ADMINISTRATION; PERIODONTICS; PERIODONTITIS; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; TISSUE LEVEL;

EID: 0030477723     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1996.67.12.1307     Document Type: Article

References (60)

1. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharm Rev 1979;30:293-331.
2. Piper PJ. Pharmacology of leukotrienes. Br Med Bull 1983;39:255-259.
3. Higgs GA. The role of eicosanoids in inflammation. Prog Lipid Res 1986;25:555-561.
4. Goldyne ME, Winklemann RK, Ryan RJ. Prostaglandin activity in human cutaneous inflammation: detection by radioimmunoassay. Prostaglandins 1973;4:737-749.
5. Trang LE, Granstrom E, Lougren D. Levels of prostaglandins F2α and E2 and thromboxane B2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 1977;6:151-154.
6. Rae SA, Davidson EM, Smith MJH. Leukotriene B4 as an inflammatory mediator in gout. Lancet 1982;ii:1122-1124.
7. Klickstein LB, Shapleigh C, Goetzl EJ. Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis. J Clin Invest 1980;66:1166-1170.
8. Solomon LM, Juhlin L, Kirschenbaum MB. Prostaglandins of cutaneous vasculature. J Invest Derm 1968;51:280-282.
9. Williams TJ, Peck MJ. Role of prostaglandin mediated vasodilation in inflammation. Nature 1977;270:530-532.
10. Ferreira SH. Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol 1972;240:200-203.
11. Ferreira SH. Prostaglandins, pain and inflammation. Agents Actions 1986;19(Suppl.):91-98.
12. Cooper SA, Mardirossian G. Comparison of flurbiprofen and aspirin in the relief of postsurgical pain using the dental pain model. Am J Med 1986;80(Suppl. 3a)36-40.
13. Dionne RA, Cooper SA. Evaluation of pre-operative ibuprofen for post-operative pain after removal of third molars. Oral Surg Oral Med Oral Pathol 1978;45:851-856.
14. Hargreaves KM, Troullos E, Dionne R. Pharmacologic rationale for the treatment of acute pain. Dent Clin N Am 1981;31:675-694.
15. Malmberg AB, Yaksh TL. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 1992;257:1276-1279.
16. Kingston AE, Kay JE, Ivanyi J. The effect of prostaglandin E and I analogues on lymphocyte stimulation. Int J Immunopharmacol 1985;7:57-64.
17. Dietrich JW, Goodson JM, Raisz LG. Stimulation of bone resorption by various prostaglandins in organ culture. Prostaglandins 1975;10: 231-238.
18. Farr D, Pochal W, Brown M, et al. Effects of prostaglandins on bone cell calcium. Arch Oral Biol 1984;29:885-891.
19. 2 acts at two distinct pathways of T lymphocyte activation: inhibition of IL-2 production and down regulation of transferrin receptor expression. J Immunol 1985;135:1172-1179.
20. 2 induction of suppressor T lymphocytes. J Immunol 1984;132:1851-1857.
21. Phipps RP, Stein SH, Rober RL. A new view of prostaglandin E regulation of the immune response. Immunol Today 1991;12:349-352.
22. Klein DC, Raisz LG. Prostaglandins: Stimulation of bone resorption in tissue culture. Endocrinol 1970;86:1436-1440.
23. Offenbacher S, Odle BM, Gray RC, Van Dyke TE. Crevicular fluid prostaglandin E levels as a measure of the periodontal disease status of adult and juvenile periodontitis patients. J Periodont Res 1984;19: 1-13.
24. El Attar TMA, Lin HS. Prostaglandins in gingiva of patients with periodontal disease. J Periodontol 1981;52:16-19.
25. Offenbacher S, Farr DH, Goodson JM. Measurement of prostaglandin E in the crevicular fluid. J Clin Periodont 1991;18:359-367.
26. 2 levels as a predictor of periodontal attachment loss. J Periodont Res 1986;21:101-112.
27. Williams RC, Jeffcoat MK, Howell TH, et al. Ibuprofen: an inhibitor of alveolar bone resorption in beagles. J Periodont Res 1988;23: 225-229.
28. Williams RC, Jeffcoat MK, Howell TH, et al. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989;60:485-490.
29. Ford-Hutchinson AW, Bray MA, Shipley ME, Doig MV, Smith JJH. Leukotriene B4: A potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 1980;286: 264-265.
30. Palmblad J, Malmsten CL, Uden AM, et al. Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence. Blood 1981;58:658-661.
31. Kennedy I, Coleman R, Humphrey PPA, Levy GP, Lumley P. Studies on characterization of prostanoid receptors: A proposed classification. Prostaglandins 1982;24:667-689.
32. 2 receptors on human peripheral blood monocytes. Scand J Immunol 1985;21:167-172.
33. Rossi AG, O'Flaherty JT. Prostaglandin binding sites in human PMNs. Prostaglandins 1989;37:641-653.
34. Lin AH, Ruppel PL, Gorman RR. Leukotriene B4 binding to human neutrophils. Prostaglandins 1984;28:837-849.
35. 2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64:432-444.
36. Abramson MM, Wolff LF, Aeppli DM, Hardie NA, Friedman H. Flurbiprofen effect on prostaglandin/thromboxane levels in human crevicular fluid. J Dent Res 1990;69(Spec. Issue):219(Abstr. 885).
37. 2 tissue levels increase following third molar extraction. J Dent Res 1992;71(Spec. Issue):178 (Abstr. 582).
38. Delgado JMR, Defeudis FV. Dialytrode for long term intracerebral perfusion in awake monkeys. Arch Int Pharmacodyn Ther 1972;198: 7-21.
39. Arner P, Bolinder J. Microdialysis of adipose tissue. J Int Med 1991;230:381-386.
40. Hamberger A, Jacobson I, Nystrom B, Sandberg M. Microdialysis sampling of the neuronal environment in basic and clinical research. J Int Med 1991;230:375-380.
41. Jarry H, Einsparrier A, Kanpiesser L, et al. Release and effects of oxytoicin on estradiol and progesterone secretion in porcine corpora lutea as measured by an in vivo microdialysis system. Endocrinol 1990;126:2350-2358.
42. Hargreaves KM, Costello A. Glucocorticoids suppress release of immunoreactive bradykinin from inflamed tissue as evaluated by microdialysis probes. Clin Pharmacol Ther 1990;48:168-178.
43. Swift JQ, Garry MG, Radeck G, Hargreaves KM. Microdialysis probes - clinical implications of a new technique for determining tissue levels of inflammatory mediators. J Oral Maxillofac Surg 1991(Suppl. 8);49:64.
44. Hargreaves KM, Dionne RA. Evaluating endogenous mediators of pain and analgesia in clinical studies. In: Portenoy MMR, Laska E, eds. Advances in Pain Research and Therapy. New York: Raven Press; 1991:18.
45. 1 alpha and TXB2 synthesis along rabbit nephron. Am J Physiol 1987;252:F53-F59.
46. Lavigne G, Hargreaves KM, Schmidt E, Dionne R. Proglumide potentiates morphine analgesia for acute post-operative pain. Clin Pharmacol Ther 1989;45:666-673.
47. Hargreaves KM, Mueller G, Dubner R, et al. Corticotropin releasing factor (CRF) produces analgesia in humans and rats. Brain Res 1987;422:154-157.
48. Hargreaves KM, Schmidt E, Mueller G, Dionne R. Dexamethasone alters plasma levels of beta-endorphin and post-operative pain. Clin Pharmacol Ther 1987;42:601-607.
49. Mendieta CF, Reeve CM, Romero JC. Biosynthesis of prostaglandins in gingiva of patients with chronic periodontitis. J Periodontol 1985;56:44-47.
50. Marcus AJ, Safier LB, Ullman H, et al. Eicosanoid production during platelet-neutrophil interactions. In: Hayaishi O, Yammamoto S, eds. Advances in Prostaglandin, Thromboxane and Leukotriene Research. New York: Raven Press; 1985:527-532.
51. 2, iLTB4, i bradykinin and i substance P in surgery patients. J Dent Res 1994;73(Spec. Issue):190(Abstr. 182).
52. Troullos E, Hargreaves KM, Butler D, Dionne R. Comparison of two NSAIDs, flurbiprofen and ibuprofen, to methylprednisolone for suppression of post-operative pain and edema. J Oral Surg 1989;48: 945-952.
53. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs. Nature New Biol 1971;231:232-235.
54. Smith WL, Lands WEM. Stimulation and blockage of prostaglandin biosynthesis. J Biol Chem 1971;246:6700-6702.
55. Williams RC, Offenbacher S, Jeffcoat MK, et al. Indomethacin or flurbiprofen treatment of periodontitis in beagles: effect on crevicular fluid arachidonic acid metabolites compared with effect on alveolar bone loss. J Periodont Res 1988;23:134-138.
56. Offenbacher S, Odle BM, Branswell LD, et al. Changes in cyclooxygenase metabolites in experimental periodontitis in Macaca mulatta. J Periodont Res 1989;24:63-74.
57. Vogel RI, Des Jardins PI, Mayor KVO. Comparison of pre-surgical and immediate post-surgical ibuprofen on post-operative periodontal pain. J Periodontol 1992;63:914-918.
58. Swift JQ, Garry MG, Roszkowski MT, Hargreaves KM. Effect of flurbiprofen on tissue levels of immunoreactive bradykinin and acute postoperative pain. J Oral Maxillofac Surg 1993;51:112-116.
59. Sisk A, Bonnington G. Evaluation of methylprednisolone and flurbiprofen for inhibition of post-operative inflammatory response. Oral Surg Oral Med Oral Pathol 1985;60:137-145.
60. Milles M, Desjardins P, Pawel H, Frey E. The effects of low dose methylprednisolone on post-operative facial swelling. J Dent Res 1986;65(Spec. Issue):788(Abstr. 564).